175 related articles for article (PubMed ID: 9083472)
1. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.
Di Fabio R; Capelli AM; Conti N; Cugola A; Donati D; Feriani A; Gastaldi P; Gaviraghi G; Hewkin CT; Micheli F; Missio A; Mugnaini M; Pecunioso A; Quaglia AM; Ratti E; Rossi L; Tedesco G; Trist DG; Reggiani A
J Med Chem; 1997 Mar; 40(6):841-50. PubMed ID: 9083472
[TBL] [Abstract][Full Text] [Related]
2. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
[TBL] [Abstract][Full Text] [Related]
4. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
Mugnaini M; Antolini M; Corsi M; van Amsterdam FT
J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
[TBL] [Abstract][Full Text] [Related]
5. Substituted analogues of GV150526 as potent glycine binding site antagonists in animal models of cerebral ischemia.
Di Fabio R; Conti N; De Magistris E; Feriani A; Provera S; Sabbatini FM; Reggiani A; Rovatti L; Barnaby RJ
J Med Chem; 1999 Sep; 42(18):3486-93. PubMed ID: 10479281
[TBL] [Abstract][Full Text] [Related]
6. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
Carling RW; Leeson PD; Moore KW; Moyes CR; Duncton M; Hudson ML; Baker R; Foster AC; Grimwood S; Kemp JA; Marshall GR; Tricklebank MD; Saywell KL
J Med Chem; 1997 Feb; 40(5):754-65. PubMed ID: 9057862
[TBL] [Abstract][Full Text] [Related]
7. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
[TBL] [Abstract][Full Text] [Related]
8. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
Baron BM; Harrison BL; McDonald IA; Meldrum BS; Palfreyman MG; Salituro FG; Siegel BW; Slone AL; Turner JP; White HS
J Pharmacol Exp Ther; 1992 Sep; 262(3):947-56. PubMed ID: 1388205
[TBL] [Abstract][Full Text] [Related]
9. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
[TBL] [Abstract][Full Text] [Related]
10. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
[TBL] [Abstract][Full Text] [Related]
11. Cycloalkyl indole-2-carboxylates as useful tools for mapping the "north-eastern" region of the glycine binding site associated with the NMDA receptor.
Micheli F; Di Fabio R; Capelli AM; Cugola A; Curcuruto O; Feriani A; Gastaldi P; Gaviraghi G; Marchioro C; Orlandi A; Pozzan A; Quaglia AM; Reggiani A; van Amsterdam F
Arch Pharm (Weinheim); 1999 Mar; 332(3):73-80. PubMed ID: 10228452
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of 1,2,3,4-tetrahydroquinoline-2,3,4-trione 3-oximes: novel and highly potent antagonists for NMDA receptor glycine site.
Cai SX; Zhou ZL; Huang JC; Whittemore ER; Egbuwoku ZO; Lü Y; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1996 Aug; 39(17):3248-55. PubMed ID: 8765507
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
Calabri FR; Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A
Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
[TBL] [Abstract][Full Text] [Related]
16. [3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.
Baron BM; Siegel BW; Harrison BL; Gross RS; Hawes C; Towers P
J Pharmacol Exp Ther; 1996 Oct; 279(1):62-8. PubMed ID: 8858976
[TBL] [Abstract][Full Text] [Related]
17. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
[TBL] [Abstract][Full Text] [Related]
18. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
19. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
[TBL] [Abstract][Full Text] [Related]
20. Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression.
Nowak G; Ossowska G; Jopek R; Papp M
Pol J Pharmacol; 1998; 50(4-5):365-9. PubMed ID: 10091723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
